Download PDF
1 / Pages

Other users also viewed these articles

Rationale and evidence on the use of tocilizumab in COVID-19: a systematic review A. Cortegiani; M. Ippolito; M. Greco; V. Granone; A. Protti; C. Gregoretti; A. Giarratano; S. Einav; M. Cecconi;
Pulmonol. 2021;27:52-66
Predictors of intubation in COVID-19 patients treated with out-of-ICU continuous positive airway pressure N. De Vita; L. Scotti; G. Cammarota; F. Racca; C. Pissaia; C. Maestrone; D. Colombo; C. Olivieri; F. Della Corte; F. Barone-Adesi; P. Navalesi; R. Vaschetto;
Pulmonol. 2022;28:173-80
Plasmapheresis reduces cytokine and immune cell levels in COVID-19 patients with acute respiratory distress syndrome (ARDS) Seyed MohammadReza Hashemian; Navid Shafigh; Golnaz Afzal; Hamidreza Jamaati; Payam Tabarsi; Majid Marjani; Majid Malekmohammad; Seyed Mehdi Mortazavi; Batoul Khoundabi; Davood Mansouri; Afshin Moniri; Abbas Hajifathali; Elham Roshandel; Esmaeil Mortaz; Ian M Adcock;
Pulmonol. 2021;27:486-92